'Unheard of' responses to bluebird CAR-T therapy seen in myeloma study - Reuters

'Unheard of' responses to bluebird CAR-T therapy seen in myeloma study Reuters (Reuters) - More than half of patients with advanced multiple myeloma who had run out of therapeutic options remained in complete remission after receiving bluebird bio Inc's experimental gene-modifying immunotherapy in a small, early stage study ... and more »

from Health - Google News http://ift.tt/2jja3UO